Insights

Cutting-edge Technology Elephas is leveraging innovative technologies such as TensorFlow, Preact, and Microsoft Azure in their ex-vivo platform to assess live tumor responses. This advanced tech stack provides a competitive edge and opens avenues for partnerships with technology-focused organizations.

Strategic Partnerships Recent collaborations with prestigious institutions like the Mayo Clinic showcase Elephas' commitment to developing oncology imaging diagnostics for predicting immunotherapy responses. Leveraging these partnerships can lead to joint sales efforts and leveraging the reputation of renowned healthcare providers.

Significant Funding With a recent $55 million Series C funding round led by prominent investment funds, Elephas has the financial backing to scale operations and potentially expand their market reach. This funding can be an indicator of growth opportunities and potential sales prospects with increased resources.

Revenue Potential Elephas falls within the revenue range of $10 million to $50 million, indicating a mid-sized company with a solid financial standing. Targeting such companies for partnerships or sales collaborations can lead to mutually beneficial opportunities for revenue growth and market expansion.

Market Differentiation Elephas' focus on ex-vivo platforms for assessing live patient biopsies sets them apart in the biotechnology research industry, offering a unique proposition for potential buyers seeking cutting-edge solutions. Highlighting this differentiation can attract customers looking for innovative approaches to cancer care.

Similar companies to Elephas

Elephas Tech Stack

Elephas uses 8 technology products and services including jsDelivr, Preact, TensorFlow, and more. Explore Elephas's tech stack below.

jsDelivr
Content Delivery Network
Preact
Javascript Libraries
TensorFlow
Machine Learning
Microsoft Azure
Platform As A Service
reCAPTCHA
Security
HSTS
Security
Bootstrap
UI Frameworks
Zoom
Web Conferencing

Media & News

Elephas's Email Address Formats

Elephas uses at least 1 format(s):

Elephas Email Formats	Example	Percentage
FLast@elephas.com	JDoe@elephas.com	94%
FirstLast@elephas.com	JohnDoe@elephas.com	3%
FiLast@elephas.com	JoDoe@elephas.com	1%
LastFir@elephas.com	DoeJoh@elephas.com	2%

Frequently Asked Questions

Where is Elephas's headquarters located?

Elephas's main headquarters is located at Madison, WI US. The company has employees across 3 continents, including North AmericaEuropeSouth America.

What is Elephas's stock symbol?

Elephas is a publicly traded company; the company's stock symbol is N/A.

What is Elephas's official website and social media links?

Elephas's official website is elephas.com and has social profiles on LinkedIn.

How much revenue does Elephas generate?

As of September 2024, Elephas's annual revenue reached $15M.

What is Elephas's SIC code NAICS code?

Elephas's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Elephas have currently?

As of September 2024, Elephas has approximately 123 employees across 3 continents, including North AmericaEuropeSouth America. Key team members include Chief Executive Officer: M. A.Chief Executive Officer: M. A.Chief Executive Officer: M. A.. Explore Elephas's employee directory with LeadIQ.

What industry does Elephas belong to?

Elephas operates in the Biotechnology Research industry.

What technology does Elephas use?

Elephas's tech stack includes jsDelivrPreactTensorFlowMicrosoft AzurereCAPTCHAHSTSBootstrapZoom.

What is Elephas's email format?

Elephas's email format typically follows the pattern of . Find more Elephas email formats with LeadIQ.

How much funding has Elephas raised to date?

As of September 2024, Elephas has raised $55M in funding. The last funding round occurred on Jan 24, 2024 for $55M.

When was Elephas founded?

Elephas was founded in 2020.

Elephas

Biotechnology ResearchWisconsin, United States51-200 Employees

Elephas is developing an ex-vivo technology suite to assess how live tumor fragments (LTFs) respond to immunotherapies. We seek to remove the trial-and-error approach to cancer care by harnessing the latest advances in cancer biology, advanced imaging, and artificial intelligence to accelerate drug development and empower clinical decision-making. Our unique approach maintains the native 3-dimensional cellular architecture and micro-environment of the tumor, enabling rapid real-time characterization of live tumor sample response to immunotherapies.

Company Overview

Headquarters: Madison, WI US
Website: elephas.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: N/A
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2020
Employees: 51-200

Media & News

Funding & Financials

$55M
Elephas has raised a total of $55M of funding over 6 rounds. Their latest funding round was raised on Jan 24, 2024 in the amount of $55M.
$10M$50M
Elephas's revenue is in the range of $10M$50M

Funding & Financials

$55M
Elephas has raised a total of $55M of funding over 6 rounds. Their latest funding round was raised on Jan 24, 2024 in the amount of $55M.
$10M$50M
Elephas's revenue is in the range of $10M$50M

Company Leadership

M. A.
Chief Executive Officer
✕
Access Insights for Elephas and Millions of Other Companies
Sign up for full access to Elephas information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Elephas and Millions of Other Companies
Sign up for full access to Elephas information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. A.
Chief Executive Officer
✕
Access Insights for Elephas and Millions of Other Companies
Sign up for full access to Elephas information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Elephas and Millions of Other Companies
Sign up for full access to Elephas information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. A.
Chief Executive Officer
✕
Access Insights for Elephas and Millions of Other Companies
Sign up for full access to Elephas information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Elephas and Millions of Other Companies
Sign up for full access to Elephas information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. B.
Chief Financial Officer
✕
Access Insights for Elephas and Millions of Other Companies
Sign up for full access to Elephas information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Elephas and Millions of Other Companies
Sign up for full access to Elephas information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
G. O.
Vice President Of Business Development
✕
Access Insights for Elephas and Millions of Other Companies
Sign up for full access to Elephas information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Elephas and Millions of Other Companies
Sign up for full access to Elephas information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

G. O.
Vice President Of Business Development
✕
Access Insights for Elephas and Millions of Other Companies
Sign up for full access to Elephas information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Elephas and Millions of Other Companies
Sign up for full access to Elephas information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. T.
Vice President Operations
✕
Access Insights for Elephas and Millions of Other Companies
Sign up for full access to Elephas information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Elephas and Millions of Other Companies
Sign up for full access to Elephas information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. W.
Vice President, Commercial
✕
Access Insights for Elephas and Millions of Other Companies
Sign up for full access to Elephas information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Elephas and Millions of Other Companies
Sign up for full access to Elephas information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. J.
Vice President Research And Development
✕
Access Insights for Elephas and Millions of Other Companies
Sign up for full access to Elephas information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Elephas and Millions of Other Companies
Sign up for full access to Elephas information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. C.
Head Of Talent Acquisition
✕
Access Insights for Elephas and Millions of Other Companies
Sign up for full access to Elephas information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Elephas and Millions of Other Companies
Sign up for full access to Elephas information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Elephas

Turing

Landmark

DataRobot

H2O.ai

Databricks

Modzy

Dataiku

Aible

Elephas Tech Stack

Media & News

Elephas Biosciences Corp. is developing advanced imaging platform.

Elephas Biosciences Corp. is developing oncology imaging diagnostics platform on Feb 1st '24.

Elephas Biosciences Corp. partnered with Mayo on Feb 20th '24.

Elephas Biosciences Corp. is developing oncology diagnostics platform on Feb 20th '24.

Venture Investors LLC invested into Elephas Biosciences Corp. $55M on Jan 23rd '24.

Elephas Biosciences Corp. received financing of $55M in Series C on Jan 23rd '24.

Elephas Biosciences Corp. is developing ex-vivo platform.

Elephas's Email Address Formats

Frequently Asked Questions

Where is Elephas's headquarters located?

What is Elephas's stock symbol?

What is Elephas's official website and social media links?

How much revenue does Elephas generate?

What is Elephas's SIC code NAICS code?

How many employees does Elephas have currently?

What industry does Elephas belong to?

What technology does Elephas use?

What is Elephas's email format?

How much funding has Elephas raised to date?

When was Elephas founded?

Elephas

Company Overview

Media & News

Elephas Biosciences Corp. is developing advanced imaging platform.

Elephas Biosciences Corp. is developing oncology imaging diagnostics platform on Feb 1st '24.

Elephas Biosciences Corp. partnered with Mayo on Feb 20th '24.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?